BioCentury
ARTICLE | Clinical News

Isolex and Isolex 300i magnetic cell selection systems regulatory update

July 12, 1999 7:00 AM UTC

The FDA granted marketing approval for NEXL’s Isolex systems to select hematopoietic stem cells and remove tumor cells from autologous peripheral blood as part of cancer therapy. NEXL said it will ins...